Table 6.
Effect of nanoencapsulation on the biochemical composition of EOs.
| Volatile Compound | RI a | Identification | Percentage (%) d | |
|---|---|---|---|---|
| EO b | NE c | |||
| Alpha Pinene | 4.449 | MS | 0.143 | 0.143 |
| Camphene | 4.609 | MS | 0.490 | 0.490 |
| Β-Phellandrene | 4.903 | RI, MS | 0.030 | 0.030 |
| Sabinene | 5.328 | RI, MS | 0.324 | 0.324 |
| β-Pinene | 5.448 | RI, MS, Co-GC | 6.275 | 6.275 |
| p-Cymene | 5.585 | RI, MS, Co-GC | 0.570 | 0.570 |
| α-Terpinene | 5.990 | RI, MS | 0.254 | 0.254 |
| Limonene | 6.476 | RI, MS, Co-GC | 15.870 | 15.870 |
| 1,8-Cineole | 6.580 | RI, MS, Co-GC | 0.293 | 0.293 |
| Γ-Terpinene | 7.369 | RI, MS, Co-GC | 10.178 | 10.178 |
| Linalool | 8.499 | RI, MS, Co-GC | 9.020 | 4.498 |
| Terpinen-4-Ol | 10.778 | RI, MS, Co-GC | 0.134 | 0.134 |
| 1,3-Cyclohexadiene-1-Methanol,4-(1-Methylethyl)- | 11.135 | RI, MS, Co-GC | 0.272 | 0.272 |
| Carvone | 11.675 | RI, MS | 23.968 | 23.968 |
| Cumunaldehyde | 13.334 | RI, MS | 19.820 | 19.820 |
| 2-Caren-10-Al | 14.841 | RI, MS, Co-GC | 0.101 | 4.410 |
| 3-Caren-10-Al | 15.064 | MS | 10.031 | 10.031 |
| (+)-2-Bornanone | 15.634 | MS | 0.145 | 0.145 |
| Geranyl Acetate | 40.731 | RI, MS | 0.221 | 0.221 |
| 100 | 100 | |||
Components are listed in order of elution in apolar column (HP-5); RI a: retention indices relative to (C7-C20) n-alkanes on the HP-Innowax, MS = mass spectrum, Co-GC = co-injection with authentic compound; nd: not detected. EO b: combined essential oils (EOcu: EOca: EOco, 19.10: 60.07: 20.84%, v/v). NE c: combined EO encapsulated (EOCU: EOCA: EOCO NE, 19.07: 60.0: 20.84%, v/v). d: The percentage composition was calculated from the chromatograms obtained on the HP-Innowax column.